M 030 (Nifedipine Extended-Release 30 mg)
Pill with imprint M 030 is Pink, Round and has been identified as Nifedipine extended-release 30 mg. It is supplied by Mylan Pharmaceuticals Inc..
Nifedipine is used in the treatment of raynaud's syndrome; high blood pressure; angina pectoris prophylaxis; hypertensive emergency; heart failure (and more), and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nifedipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 030
Nifedipine extended-release
- Imprint:
- M 030
- Strength:
- 30 mg
- Color:
- Pink
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- ferrosoferric oxide
ferric oxide red
hydroxypropyl cellulose
hypromelloses
magnesium stearate
polyethylene glycol
polyvinyl alcohol
propylene glycol
sodium chloride
magnesium silicate
titanium dioxide
ferric oxide yellow
cellulose acetate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0400 | UDL Laboratories Inc. |
More about nifedipine
- Nifedipine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 70 Reviews – Add your own review/rating
- Drug class: calcium channel blocking agents
Consumer resources
Other brands: Nifedical XL, Procardia, Adalat, Procardia XL, ... +3 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
